We make AI work for Science

Aganitha is a new generation in silico company that integrates high-throughput sciences with deep learning-based generative models to solve complex drug discovery and development challenges.

Bringing a new drug to market takes $1-2B and 6-12 years. Advances in scRNA, multiomics, long read sequencing, structural biology, first principles based chemistry etc. now allows us to take far less time, at a lower cost and a higher probability of success.
Our services and solutions help drive this transformation with the following foundational elements.